Acute Myeloid Leukemia — Trials

Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,964 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 789
Recruiting: 466
Ph III recruiting: 45
Growth YoY: +3.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (536)

clinicaltrialsPublishedShowing 251–300 of 2,964 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04827719	BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS	completed	Phase 2	38	Groupe Francophone des MyelodysplasiesOTHER	1	Aug 11, 2026	clinicaltrials
NCT05457010	Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS	active not recruiting	Phase 1	24	Arcellx, Inc.INDUSTRY	1	Aug 11, 2026	clinicaltrials